Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BNTX | BIONTECH SE | NASDAQ | Biotechnology | $24.43B | $101.81 | 3.09% | -$370.84M | -34.91x | 0.16 | Germany | ||
| CLMT | CALUMET INC | NASDAQ | Oil & Gas E&P | $794.83M | $9.22 | -5.53% | $164.50M | -3.45x | -4.53 | United States | ||
| ORIC | ORIC PHARMACEUTICALS INC | NASDAQ | Biotechnology | $345.90M | $4.87 | 2.10% | -$126.74M | -2.66x | 0.13 | United States | ||
| TYRA | TYRA BIOSCIENCES INC | NASDAQ | Biotechnology | $481.00M | $9.06 | 1.57% | -$85.96M | -6.00x | 0.06 | United States | ||
| SSYS | STRATASYS LTD | NASDAQ | Computer Hardware | $626.08M | $8.73 | -3.85% | -$73.65M | -5.14x | 0.30 | United States | ||
| PVLA | PALVELLA THERAPEUTICS INC | NASDAQ | Biotechnology | $280.43M | $25.45 | 4.47% | -$13.12M | -3.25x | 0.41 | United States | ||
| AKRO | AKERO THERAPEUTICS INC | NASDAQ | Biotechnology | $3.00B | $37.67 | 0.11% | -$247.12M | -10.05x | 0.10 | United States | ||
| CLAR | CLARUS CORP | NASDAQ | Leisure | $127.36M | $3.32 | 1.84% | -$27.25M | -2.42x | 0.26 | United States | ||
| CRDF | CARDIFF ONCOLOGY INC | NASDAQ | Biotechnology | $187.60M | $2.82 | -1.05% | -$45.03M | -2.97x | 0.17 | United States | ||
| RGLS | REGULUS THERAPEUTICS INC | NASDAQ | Biotechnology | $133.15M | $2.01 | -2.43% | -$45.85M | -2.45x | 0.10 | United States | ||
| REPL | REPLIMUNE GROUP INC | NASDAQ | Biotechnology | $675.03M | $8.77 | 9.63% | -$216.52M | -2.86x | 0.25 | United States | ||
| CBNA | CHAIN BRIDGE BANCORP INC | NYSE | Banks - Regional | $156.63M | $23.87 | -2.49% | $26.76M | 5.72x | 8.71 | United States | ||
| SLDB | SOLID BIOSCIENCES INC | NASDAQ | Biotechnology | $234.80M | $3.03 | 18.82% | -$119.51M | -0.99x | 0.38 | United States | ||
| ANVS | ANNOVIS BIO INC | NYSE | Biotechnology | $26.31M | $1.35 | 10.66% | -$24.59M | -0.67x | 0.50 | United States | ||
| PCVX | VAXCYTE INC | NASDAQ | Biotechnology | $3.91B | $30.39 | -0.85% | -$448.08M | -8.00x | 0.06 | United States | ||
| CGEM | CULLINAN THERAPEUTICS INC | NASDAQ | Biotechnology | $473.95M | $8.10 | 2.66% | -$166.96M | -2.91x | 0.05 | United States | ||
| PENG | PENGUIN SOLUTIONS INC | NASDAQ | Semiconductors | $843.27M | $15.71 | -1.07% | $91.31M | -92.41x | 1.99 | United States | ||
| XYZ | BLOCK INC | NYSE | Software - Infrastructure | $32.45B | $52.39 | -2.80% | $1.85B | 11.15x | 0.73 | United States | ||
| MIR | MIRION TECHNOLOGIES INC | NYSE | Specialty Industrial Machinery | $3.13B | $13.48 | -2.32% | $173.90M | -74.89x | 0.72 | United States | ||
| QNCX | QUINCE THERAPEUTICS INC | NASDAQ | Biotechnology | $46.20M | $1.05 | 5.95% | -$56.56M | -0.80x | 2.80 | United States | ||
| RCUS | ARCUS BIOSCIENCES INC | NYSE | Biotechnology | $816.04M | $7.71 | -2.16% | -$261.00M | -2.46x | 1.37 | United States | ||
| FBLG | FIBROBIOLOGICS INC | NASDAQ | Biotechnology | $52.07M | $1.38 | 15.97% | -$10.57M | -4.06x | 5.01 | United States | ||
| OLMA | OLEMA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $324.58M | $4.75 | 7.47% | -$127.93M | -2.16x | 0.10 | United States | ||
| PRQR | PROQR THERAPEUTICS NV | NASDAQ | Biotechnology | $138.88M | $1.32 | 15.79% | -$26.21M | -3.79x | 0.90 | Netherlands | ||
| PCT | PURECYCLE TECHNOLOGIES INC | NASDAQ | Pollution & Treatment Controls | $998.01M | $5.57 | -7.10% | -$197.66M | -3.18x | 3.42 | United States | ||
| VERA | VERA THERAPEUTICS INC | NASDAQ | Biotechnology | $1.35B | $21.11 | -0.85% | -$142.35M | -7.68x | 0.14 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.